Last reviewed · How we verify

NCT05330039: IEM

Characterization of Intestinal Microbiota in Children With Inborn Errors of Metabolism (IEM)

Completed Last updated 1 March 2024
What this trial tests

trial in Inborn Errors of Metabolism in 22 participants. Completed in 27 February 2024.

Timeline
30 November 2021
Primary endpoint
27 February 2024
27 February 2024

Quick facts

Lead sponsorEmma Marie Caroline Slack
StatusCompleted
Study typeOBSERVATIONAL
Enrollment22
Start date30 November 2021
Primary completion27 February 2024
Estimated completion27 February 2024
Sites1 location across Switzerland

Conditions studied

Sponsor

Emma Marie Caroline Slack

Who can join

Under 18, any sex, with Inborn Errors of Metabolism or Propionic Aciduria. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study around children with inborn errors of metabolism (IEM) and their healthy siblings. Collection of stool and urine to assess contribution of microbiota to disease severity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Inborn Errors of Metabolism

Currently open trials in the same condition.

Other Emma Marie Caroline Slack trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05330039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing